Dysregulation of TRKB and its activating neurotrophin BDNF play a role in tumorigenesis and metastasis in a wide range of carcinomas (Han et al, 2007) but, to our knowledge, a role for TRKB in sarcoma tumorigenesis and metastasis development has not previously been described. This evidence concerns the gene NTRK2 and carcinoma.